Codexis, Inc. (CDXS) Investor Relations Documents

Codexis, Inc. (CDXS) investor relations documents from the company's IR site: 15 presentations, 25 press releases; latest deck 2026-06-02. Read in-app with summaries. First-party data.

Codexis Corporate Presentation June 2026: Codexis June 2026 corporate presentation highlights its ECO Synthesis platform for scalable RNAi manufacturing, supported by $65 million in cash through 2027.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseCodexis Reports Second Quarter 2026 Financial Results
2026-08-03Press releaseCodexis Appoints David Butler, PhD, to Strategic Advisory Board
2026-07-28Press releaseCodexis to Report Second Quarter 2026 Financial Results on August 11
2026-07-23Press releaseCodexis Announces Pricing of Public Offering of Common Stock
2026-07-23Press releaseCodexis Announces Proposed Public Offering of Common Stock
2026-06-02PresentationCodexis Corporate Presentation June 2026
2026-05-20Press releaseCodexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
2026-05-07Press releaseCodexis Reports First Quarter 2026 Financial Results
2026-04-29Press releaseCodexis to share RNA manufacturing advances at TIDES USA
2026-04-23Press releaseCodexis to Report First Quarter 2026 Financial Results on May 7
2026-03-11Press releaseCodexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
2026-03-04Press releaseCodexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
2026-02-25Press releaseCodexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
2025-11-06PresentationView Latest Investor Presentation
2025-08-13Earnings deckPresentationPDF
2025-08-13PresentationCodexis Corporate Presentation August 2025
2025-05-14Earnings deckPresentationPDF
2025-02-27Earnings deckPresentationPDF
2025-02-14Press releaseCodexis Announces New Employment Inducement Grants
2025-02-05Press releaseCodexis Announces New Employment Inducement Grants
2024-10-31Earnings deckPresentationPDF
2024-10-31Press releaseCodexis Reports Third Quarter 2024 Financial Results
2024-08-08Earnings deckPresentationPDF
2024-08-08Press releaseCodexis Reports Second Quarter 2024 Financial Results
2024-05-02Earnings deckPresentationPDF
2024-04-18Press releaseCodexis to Report First Quarter 2024 Financial Results on May 2
2024-02-28Earnings deckPresentationPDF
2024-02-26Press releaseCodexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
2023-11-02Earnings deckPresentationPDF
2023-11-02Press releaseCodexis Reports Third Quarter 2023 Financial Results
2023-08-03Press releaseEarnings ReleaseHTML
2023-05-04Press releaseEarnings ReleaseHTML
2023-02-23Earnings deckPresentationPDF
2023-02-23Press releaseEarnings ReleaseHTML
2022-11-03Earnings deckPresentationPDF
2022-11-03Press releaseEarnings ReleaseHTML
2022-09-14Press releaseCodexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field
2022-08-04Earnings deckPresentationPDF
2022-08-04Press releaseEarnings ReleaseHTML
2022-05-05PresentationPresentationPDF

CDXS overview · CDXS earnings · CDXS financials · CDXS KPIs · CDXS ownership · CDXS peers · CDXS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.